How long does it take to recover from a maze surgery?

Maze Procedure Recovery Time Most patients are released from the hospital within four days after minimally invasive surgery or five to seven days for combined/open-heart surgery. It will take about three to eight weeks to go back to your normal, daily activities.

What is the success rate of the maze procedure?

The maze procedure is successful in treating AFib in 60%–70% of patients, who can often stop taking blood thinners several months after the procedure.

Can the maze procedure fail?

However, about 20–30% of the patients who underwent maze procedures have shown recurrence of AF during the follow-up periods [10], and there are few reports showing mid- to long-term results and reporting predictors of the maze failure [11–13].

What happens after a maze procedure?

Recovery takes about 6–8 weeks. About one-third of patients experience some atrial fibrillation or skipped heartbeats within a few weeks or months after maze surgery due to swelling and inflammation of atrial tissue. In addition, some patients require a pacemaker following surgery.

What is the maze procedure for atrial fibrillation?

The maze procedure is the surgical ablation approach with the greatest long-term success in treating atrial fibrillation. The maze procedure includes creation of lines of conduction block (scar tissue) that block the abnormal impulses that cause atrial fibrillation,…

How does a doctor make a maze in the heart?

A doctor creates a pattern of scar tissue (the maze) in the upper chambers of the heart by applying heat or cold. Or, the doctor uses a scalpel to make several precise incisions.

What is a maze procedure?

What is a Maze procedure? The Maze procedure is a type of heart surgery used to treat atrial fibrillation. The heart has 4 chambers. There are 2 upper chambers called atria and 2 lower chambers called ventricles.

What’s new in atrial fibrillation surgery?

Using the very latest technology, including advanced surgical robotics, Cleveland Clinic heart surgeons can now extend treatment to virtually all patients with atrial fibrillation.